Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Innovus Pharms Inc logo

Innovus Pharms Inc

Sector: Healthcare   

Industry: Drug Manufacturers - Major

Optionable: No  Market Cap: 802 M  90-day average vol: 47,052

Previous close: 5.98  Open: 5.93  Bid: 2.39  Ask: 9.55
52 week range    
Last updated: Friday 19th July 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord



StockDividendMarket Cap (B)PEPrice ($)

INNV Income Statement

Invalid dateJun-21Jun-22Jun-23
AccretionOnPreferredStock17 M
Amortization of intangibles124 M124 M124 M
Basic EPS from continuing operations-0.36-0.05-0.3
Basic EPS total-0.36-0.05-0.3
Basic weighted shares outstanding124 M136 M136 M
Cost of sales-155 M-203 M-162 M
Depreciation12 M14 M15 M
Depreciation unreconciled12 M14 M15 M
DepreciationAndAmortization12 M14 M15 M
Diluted EPS total-0.36-0.05-0.3
Diluted normalized net income/share-0.36-0.05-0.3
Diluted weighted shares outstanding124 M136 M136 M
Earnings from equity interest10 M
EarningsFromEquityInterestNetOfTax10 M
GeneralAndAdministrativeExpense132 M102 M116 M
Gross operating profit793 M901 M850 M
Income before tax584 M759 M698 M
Income restructuring and M&A-2 M
Income taxes10 M723000.0-7 M
Interest income-3 M-2 M
InterestExpenseNonOperating17 M3 M
MinorityInterests754000.01 M3 M
MiscOtherSpecialCharges-17 M-305000.0124000.0
Net income from total operations-44 M-7 M-41 M
NetIncomeCommonStockholders575 M760 M708 M
NetIncomeContinuousOperations-44 M-7 M-41 M
NetNonOperatingInterestIncomeExpense-17 M-3 M-2 M
Operating income-12 M-4 M-49 M
Operating income before depreciation (EBITDA)614 M773 M714 M
OperatingExpense185 M140 M151 M
Other income net7 M305000.0-124000.0
OtherGandA132 M102 M116 M
OtherOperatingExpenses18 M
OtherunderPreferredStockDividend17 M
PreferredStockDividends17 M
PromotionAndAdvertising7 M7 M6 M
RentAndLandingFees5 M5 M
RestructringAndMnAIncome-2 M
Revenue per share125 M124 M124 M
Selling Gen & administrative expense155 M126 M135 M
SellingAndMarketingExpense22 M24 M20 M
Special income/charges2 M
Total Income available for interest expense (EBIT)600 M759 M698 M
Total common shares outstanding136 M136 M136 M
Total net income-44 M-7 M-41 M
Total ordinary shares136 M136 M136 M
Total revenues638 M699 M688 M
TotalExpenses30 M-63 M-12 M
TotalRevenue638 M699 M688 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University